Giant orbitotemporal neurofibromatosis

  • Diego Gutiérrez Universidad de la República, Hospital de Clínicas, Cátedra de Cirugía Plástica, Reparadora y Estética. http://orcid.org/0000-0003-4636-8903
  • Nicolás Urroz Universidad de la República, Hospital de Clínicas, Cátedra de Cirugía Plástica, Reparadora y Estética.
  • Marcelo Langleib Universidad de la República, Hospital de Clínicas, Departamento Clínico de Imagenología
Keywords: NEUROFIBROMATOSIS 1, PLEXIFORM NEUROFIBROMA, EMBOLIZATION THERAPEUTIC, PLASTIC SURGERY

Abstract

Orbitotemporal neurofibromatosis is a progressive disease that begins in childhood and may cause important morphological and functional alterations. We present the case of an adult patient with a giant orbitotemporal neurofibromatosis, which was treated by preoperative embolization and a surgical resection to reduce the size of the tumor size.

References

(1) Kapur S, Bentz ML. Pediatric tumors. En: Rodriguez ED, Losee JE, eds. Craneofacial, head and neck surgery and pediatric plastic surgery. 3rd ed. London: Elsevier- Saunders, 2013:877-92.

(2) Ferner RE, Gutmann DH. Neurofibromatosis type 1 (NF1): diagnosis and management. En: Said G, Krarup C, eds. Peripheral nerve disorders. (Handbook of Clinical Neurology, vol 115). Amsterdam: Elsevier, 2013: 939-55.

(3) Lee V, Ragge NK, Collin JR. The surgical management of childhood orbito-temporal neurofibromatosis. Br J Plast Surg 2003; 56(4):380-87.

(4) Havlik RJ, Boaz J. Cranio-orbital-temporal neurofibromatosis: are we treating the whole problem? J Craniofac Surg 1998; 9(6):529-35.

(5) Jackson IT, Carbonnel A, Potparic Z, Shaw K. Orbitotemporal neurofibromatosis: classification and treatment. Plast Reconstr Surg 1993; 92(1):1-11.

(6) Latham K, Buchanan EP, Suver D, Gruss JS. Neurofibromatosis of the head and neck: classification and surgical management. Plast Reconstr Surg 2015; 135(3):845-55.

(7) Hirbe AC, Gutmann DH. Neurofibromatosis type 1: a multidisciplinary approach to

care. Lancet Neurol 2014; 13(8):834-43.

(8) Katowitz WR, Katowitz JA. Orbitofacial neurofibromatosis 1: current medical and surgical management. En: Guthoff RF, Katowitz JA, eds. Essentials in ophthalmology. Oculoplastics and Orbit. Berlin: Springer, 2010:79-92.

(9) Li J, Lin M, Shao C, Ge S, Fan X. Blepharoplasty techniques in the management of orbito-temporal neurofibromatosis. J Plast Reconstr Aesthet Surg 2014; 67(11):1496-501.

(10) Oderich GS, Sullivan TM, Bower TC, Gloviczki P, Miller DV, Babovic-Vuksanovic D, et al. Vascular abnormalities in patients with neurofibromatosis syndrome type I: clinical spectrum, management, and results. J Vasc Surg 2007; 46(3):475-84.

(11) Littlewood AH, Stilwell JH. The vascular features of plexiform neurofibroma with some observations on the importance of pre-operative angiography and the value of pre-operative intra-arterial embolisation. Br J Plast Surg 1983; 36(4):501-6.

(12) Tomei KL, Gupta V, Prestigiacomo CJ, Gandhi CD. Spontaneous hemorrhage of a facial neurofibroma: endovascular embolization before surgical intervention. J Craniofac Surg 2013; 24(5):e514-7.

(13) Nair S, Gobin YP, Leng LZ, Marcus JD, Bilsky M, Laufer I, et al. Preoperative embolization of hypervascular thoracic, lumbar, and sacral spinal column tumors: technique and outcomes from a single center. Interv Neuroradiol 2013; 19(3):377-85.

Published
2019-04-07
How to Cite
1.
Gutiérrez D, Urroz N, Langleib M. Giant orbitotemporal neurofibromatosis. Rev. Méd. Urug. [Internet]. 2019Apr.7 [cited 2024Dec.18];35(1):67-1. Available from: https://www2.rmu.org.uy/ojsrmu311/index.php/rmu/article/view/14